NCT07693517

Brief Summary

SPINE-RISK VE is a prospective multicenter cohort study designed to develop and internally validate a multimodal preoperative predictive model for Failed Back Surgery Syndrome (FBSS), now classified as Persistent Spinal Pain Syndrome Type 2 (PSPS-T2) per ICD-11 (code MG30.51), in Venezuelan adults patients undergoing elective lumbar spine surgery. The model integrates three variable domains obtainable from routine preoperative evaluation at zero additional cost to the patient: (1) inflammatory laboratory biomarkers (C-reactive protein \[CRP\], neutrophil-to-lymphocyte ratio \[NLR\], albumin, glycated hemoglobin \[HbA1c\], erythrocyte sedimentation rate \[ESR\]); (2) preoperative lumbar magnetic resonance imaging (MRI) findings (Modic changes, Pfirrmann disc degeneration grade, foraminal stenosis, number of surgical levels, spondylolisthesis); and (3) validated psychosocial instruments (Patient Health Questionnaire-9 \[PHQ-9\], Pain Catastrophizing Scale \[PCS\], smoking status, benzodiazepine use, prior lumbar surgery). Analysis proceeds in two phases: Phase 1 applies multivariable logistic regression with Least Absolute Shrinkage and Selection Operator (LASSO) variable selection to generate a printable clinical nomogram; Phase 2 applies a random forest machine learning algorithm with 10-fold cross-validation. Model reporting follows Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis plus Artificial Intelligence (TRIPOD+AI) guidelines. SPINE-RISK VE aims to produce the first validated multimodal predictive model for PSPS-T2/FBSS was developed in a Latin American surgical cohort, providing neurosurgeons with an evidence-based preoperative risk stratification tool applicable without Additional technological infrastructure.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
17mo left

Started Sep 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 3, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 9, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

September 4, 2026

Expected
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 4, 2027

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2028

Last Updated

July 10, 2026

Status Verified

July 1, 2026

Enrollment Period

1.2 years

First QC Date

July 3, 2026

Last Update Submit

July 8, 2026

Conditions

Keywords

predictive modelmachine learningrandom forestLASSO regressionModic changesinflammatory biomarkerspain catastrophizingTRIPOD+AIVenezuelaLatin America

Outcome Measures

Primary Outcomes (1)

  • Predictive accuracy of SPINE-RISK VE model for PSPS-T2/FBSS at 12 months

    Area Under the Receiver Operating Characteristic Curve (AUC-ROC) of the multimodal predictive model (Phase 1: LASSO logistic regression nomogram; Phase 2: random forest algorithm) for identifying patients who develop Persistent Spinal Pain Syndrome Type 2 (PSPS-T2/FBSS) at 12 months post-lumbar surgery, defined as NRS \>=4 AND ODI \>=40% at postoperative follow-up assessment. Target AUC \>=0.80 per Riley et al. (Stat Med 2020) Minimum criteria for clinical prediction models.

    12 months post-lumbar surgery

Study Arms (1)

Lumbar surgery candidates

Adult patients (18 years or older) with an indication for elective lumbar spine surgery (discectomy, spinal fusion, or decompression) for degenerative lumbar disease at three Venezuelan referrals centers. All participants undergo standardized preoperative assessment, including inflammatory laboratory biomarkers, lumbar MRI morphological evaluation, and validated psychosocial instruments (PHQ-9, PCS). The primary outcome assessed at 12-month postoperative follow-up.

Other: SPINE-RISK VE multimodal preoperative assessment

Interventions

Adult patients (18 years or older) with an indication for elective lumbar spine surgery (discectomy, spinal fusion, or decompression) for degenerative lumbar disease at three Venezuelan referral centers. All participants undergo standardized preoperative assessment, including inflammatory laboratory biomarkers, lumbar MRI morphological evaluation, and validated psychosocial instruments (PHQ-9, PCS). Primary outcome assessed at 12-month postoperative follow-up

Lumbar surgery candidates

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with degenerative lumbar spine disease undergoing elective lumbar surgery (discectomy, spinal fusion, or decompression) at three Venezuelan referral centers: Hospital Universitario de Caracas and two regional Neurosurgical referral centers in Venezuela. Consecutive recruitment during the study period. This population represents a low-middle income country (LMIC) Latin American surgical cohort not previously represented in published predictive models for PSPS-T2/FBSS

You may qualify if:

  • Confirmed indication for elective lumbar spine surgery (discectomy, spinal fusion, or decompression) for degenerative lumbar disease
  • Availability of preoperative lumbar MRI (with and without gadolinium contrast) within 6 months before surgery
  • Availability of standard preoperative laboratory panel (CRP, CBC with differential, albumin, HbA1c, ESR) within 30 days before surgery
  • Ability to complete validated psychosocial instruments (PHQ-9, PCS) in Spanish
  • Provision of written informed consent prior to any study procedure
  • Attending one of the three participating Venezuelan referral centers during the recruitment period

You may not qualify if:

  • Active spinal infection or spinal tumor requiring oncological surgery
  • Traumatic spinal fracture as primary indication
  • Cognitive impairment preventing completion of self-report psychosocial instruments
  • Active psychiatric emergency at time of preoperative assessment
  • Prior participation in another clinical trial that could influence surgical or pain outcomes
  • Inability to complete 12-month postoperative follow-up (geographic inaccessibility, planned relocation, or terminal illness)
  • Age under 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopsital Universitario de Caracas

Caracas, Distrito Capitañ, 1050, Venezuela

Location

Related Publications (7)

  • von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med. 2007 Oct;45(4):247-51. doi: 10.1016/j.ypmed.2007.08.012. Epub 2007 Sep 4.

  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

  • Riley RD, Snell KI, Ensor J, Burke DL, Harrell FE Jr, Moons KG, Collins GS. Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes. Stat Med. 2019 Mar 30;38(7):1276-1296. doi: 10.1002/sim.7992. Epub 2018 Oct 24.

  • Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, Ghassemi M, Liu X, Reitsma JB, van Smeden M, Boulesteix AL, Camaradou JC, Celi LA, Denaxas S, Denniston AK, Glocker B, Golub RM, Harvey H, Heinze G, Hoffman MM, Kengne AP, Lam E, Lee N, Loder EW, Maier-Hein L, Mateen BA, McCradden MD, Oakden-Rayner L, Ordish J, Parnell R, Rose S, Singh K, Wynants L, Logullo P. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024 Apr 16;385:e078378. doi: 10.1136/bmj-2023-078378.

  • Xu W, Ran B, Zhao J, Luo W, Gu R. Risk factors for failed back surgery syndrome following open posterior lumbar surgery for degenerative lumbar disease. BMC Musculoskelet Disord. 2022 Dec 31;23(1):1141. doi: 10.1186/s12891-022-06066-2.

  • Hajilo P, Imani B, Zandi S, Mehrafshan A, Khazaei S. Risk factors analysis and risk prediction model for failed back surgery syndrome: A prospective cohort study. Heliyon. 2024 Nov 22;11(1):e40607. doi: 10.1016/j.heliyon.2024.e40607. eCollection 2025 Jan 15.

  • Khazanchi R, Kumar D, Oris RJ, Bajaj A, Herrera DE, Chen AR, Shah RM, Asthana S, Reyes SG, Bajaj P, Hsu WK, Patel AA, Divi SN. Identifying Predictors of Failed Back Surgery Syndrome Following Lumbar Spine Surgery: A Machine Learning Approach. Spine (Phila Pa 1976). 2026 May 15;51(10):736-742. doi: 10.1097/BRS.0000000000005411. Epub 2025 May 29.

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • juan j valero, Medical Doctor

    Universidad Central de Venezuela

    PRINCIPAL INVESTIGATOR

Central Study Contacts

juan j Valero, Medical Doctor

CONTACT

Fredy Contreras, PHD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator, Neurosurgeon and Pain Medicine Specialist

Study Record Dates

First Submitted

July 3, 2026

First Posted

July 9, 2026

Study Start (Estimated)

September 4, 2026

Primary Completion (Estimated)

November 4, 2027

Study Completion (Estimated)

February 10, 2028

Last Updated

July 10, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared. This study collects sensitive clinical and psychosocial data from Venezuelan patients In a low-resource setting. The research team does not have access to formal data repository infrastructure for anonymized IPD sharing that meets international data protection standards. Aggregate study results and the derived predictive model (nomogram and machine learning algorithm) will be made publicly available through peer-reviewed publication In an indexed journal.

Locations